Reddit Posts
Mentions
ASTS, SOFI, RKLB, SYM, NEUP, LUNR, SERV, WBTN, KTOS, but i dont have money to invest in all of those lol. 30 shares of SERV, 15 of LUNR, 50 of NEUP, then SOFI, SYM, and WBTN are my reoccurring investments, will probably stop once i hit 10k worth of shares in each.... will probably take me a few years though lol, hopefully.
Am I the only person here in NEUP?
Once again I am wondering if anyone here at all is in NEUP or interested? Bagholding this rn
$NEUP - she’s curling back up. Easiest 20% hit and run if I’ve ever saw one
Opened a huge position in $NEUP - buy the fear!
$NEUP is at an ATL - now is the time to buy
What sort of criteria do you look for? Honest question, I am eyeing NEUP as well and the -9% in premarket is too tempting, I will be scooping up a position
Ended up holding NEUP from 6.30 average into the weekend which isn’t what I wanted but hoping for some more upside next week. Anybody else hopeful for this? I’m just hoping it doesn’t dive too deep prior
$NEUP what a find especially on a Friday. Let’s see if she fills the gap tonight
Getting into $NEUP was the best decision I’ve made today. Has room to 2x from here there’s a huge gap to fill
$NEUP is about to take off! Look at that chart 😍
Keep an eye on $NEUP - has the potential to gap fill to $15 (2x) - huge insider buying
NEUP up 100% already and running........crazy
NEUP volume is insane for a low float - and up over 50% already - I'm not understanding it but it's fun!
NEUP premarket..... interesting 👀
Thoughts on NEUP it crashed 15 to 5 overnight now I'm down 2000 should I hold. I had a 13.40 GTC stop on Webull that didn't execute.
I had NEUP with a stop at 13.04 GTC with a profit, however it tank after market close based on it failing clinical trials and now I'm -2000 down on the stock.
It's crazy for sure! EVAX has potential huge catalyst in the morning but has grown out of penny status over the past cople of weeks. NEUP also grew out of penny status over the past several weeks, has 'potential' big news any day - one way or another. Gonna double/triple or get cut in half any day. PSTV just keeps bouncing around \~50 cents, hopefully they survive long enough to get their feet under them, which seems to be happening .....and it's difficult to account for the overall market retard factor and MMs!
Neup Low Float 🔥 → With tight supply, it doesn’t take much volume to move this. Upcoming Catalysts → Multiple trials lined up with readouts expected in the near term. No dilution risk until 2027 ✅ → Huge plus compared to most small-cap biotechs constantly raising. Partnership already in place 🤝 → Shows validation and support from bigger players. Pipeline depth → More than a one-trick pony. 💡 If the upcoming trial data hits, NEUP could run like we’ve seen DRUG or other small-float biotech names do recently. Risk is always there in biotech, but the setup looks strong. Not financial advice, but worth watching closely. 👀
Loving my NEUP today! wow.....
Not a penny stock but hopefully NEUP goes back up again 😭 I’ll be holding though
Look at the 5 day on NEUP Look at the MC and that it's basically trading close to cash on hand. Phase 3 coming up with Merck with huge market. That's why it's up, and that's why it has room to run almost exponentially on good news. Low debt, solid management, validation with Merck as a partner, upcoming catalysts - imagine if they're successful in a non-drowsy non-altering anxiety med! Though it's up it's still a steal and hidden gem. Low float means it's rocket on good news, look at what's happened with it just being 'found'. More will find it after the run this week and we go. Will be a 2x gainer by next week. Do your own DD, but the DD is pretty irrefutable.
Sold NEUP at open, 12% to the bag. It was a little bit more but the slippage fucked me lol.
Additionally, look at NEUP. Trading at or below cash, several catalysts on the horizon, Merck as a partner is strong validation, low float and market cap is stupidly low - it's being found (today it seems like it was found as volume was more than 10x normal which is crazy, but good! It will be 'more found' tomorrow when everyone sees it went up 24% today. Seems undervalued with a long way to run up just to get to fair valuation. I'm holding long there, just someting to check out on your own if you're kicking around ideas.
Anyone know what is happening with NEUP? Way more volume than usual and up 25%
NEUP starting to move nicely last couple days...shout out u/Straight-Annual8687 for sharing
NEUP running today. Company still trading below cash and with great catalysts upcoming, plus partner with Merck. Hidden gem. Did a post on it yesterday, seems fortuitious timing.
NEUP my go to play for these days, hasn't run yet and the DD is solid
Thoughts on NEUP? Trading below its cash of $17M and looks like plenty of cash and low burn rate. Has 2 Phase 3 assets with first data readout targeted this quareter plus an Alzheimer drug in Phase 2 which is partnered with Merck. With positive results this seems like a huge upside. Low volume, low share count squeeze anything out pretty quickly. And potential buyout (?). Anyway -thoughts? I'm sure I'm missing siomething? I'm in for 2000 shares and thinking about buying more. Seems like a rocket repeat of RIGL maybe (?)
NEUP: Why isn't this a 10x+ bagger in the making? Market cap 15M, profit margin 37%, 17M cash, 15M revenue, partnered trials with Merck and Carina on top of own development in Phase 2 and Phase 3, wide market potentials for PTSD, SAD, Alzheimers, cancers. It's trading below its cash with two Phase 3 assests coming out in Q3 and large big pharma partners. Low volume = rapid upside with positive results - seems like a sleeper, with good timing? Looking forward to thoughts / comments about taking long position.
NEUP - cheapest phase 3 biotech play valued at less than 20 million. Products have wide market base. Trading below it's cash of $15M, and partnered with Merck and Carina. Charts and summary look great. Unsure what I'm missing but seems like a helluva launch is on the horizon, like a buyout or licensing agreement $$$$
NEUP long - you get a company trading below its cash of 15 million, that is well financed through late 2026, and which has 2 Phase 3 assets with first data readout in Q3 and an Alzheimer drug in Phase 2 which is partnered with pharma giant Merck. With likely positive phase 3 results this is going to explode toward $50. Or possible acquisition. This is not a YOLO in a week gamble - this is a buy and hold with high likelihood of 3x-10x+ over the next several months. There's a lot to like and multiple mature paths to significant upside. Check it out and DD of course to ensure it's for you.
Yahoo finance shows $NEUP insiders owning 352%. How does that work?
As we move into August, personally doing some DD on NEUP and SKYE. Positions: IXHL, RR, CISO